Abstract
The aim of the study was to assess the completeness and accuracy of cancer registration for cutaneous malignant melanoma. The study was conducted in seven health districts in England and one health board in Scotland from 1987 to 1989 with a total resident population of 3.6 million. Records from pigmented lesion clinics and pathology laboratories collected during the Cancer Research Campaign's health education programme to promote the early detection of melanoma were matched with cancer registrations from a total of five regional cancer registries. In England 74% out of a total of 642 cases of invasive malignant melanomas (ICD 172) and 44% out of a total of 155 in situ melanomas (ICD 232) had been registered compared with 96% and 100% respectively in Scotland. A significantly higher proportion of late-stage cases was found among registered than among non-registered cases in England (P < 0.001). In all registries the majority of superficial spreading in situ melanomas were miscoded as invasive cases. The annual incidence of invasive malignant melanoma in the English study areas was found to be seven per 100,000 in men and 11 per 100,000 in women, similar to that reported in Scotland. The registries are best at recording thick or late-stage melanomas. As the skin cancer target for Health of the Nation depends on monitoring trends in the incidence of malignant melanoma, future improved ascertainment of cases and changes in the type of cases being registered must be taken into account.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benn R. T., Leck I., Nwene U. P. Estimation of completeness of cancer registration. Int J Epidemiol. 1982 Dec;11(4):362–367. doi: 10.1093/ije/11.4.362. [DOI] [PubMed] [Google Scholar]
- Bonett A., Roder D., Esterman A. Epidemiological features of melanoma in South Australia: implications for cancer control. Med J Aust. 1989 Nov 6;151(9):502-4, 506-9. [PubMed] [Google Scholar]
- Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choyce A., McAvoy B. R. Cervical cancer screening and registration--are they working? J Epidemiol Community Health. 1990 Mar;44(1):52–54. doi: 10.1136/jech.44.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark W. H., Jr, Elder D. E., Guerry D., 4th, Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24):1893–1904. doi: 10.1093/jnci/81.24.1893. [DOI] [PubMed] [Google Scholar]
- Codling B. W., Pheby D., Hagen D. L., Duffin M. F. Cancer registration by linking pathology and district PAS data. Br J Cancer. 1990 Aug;62(2):271–274. doi: 10.1038/bjc.1990.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colloby P. S., West K. P., Fletcher A. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol. 1991 Mar;163(3):245–250. doi: 10.1002/path.1711630310. [DOI] [PubMed] [Google Scholar]
- English D. R., Heenan P. J., Holman C. D., Armstrong B. K., Blackwell J. B., Kelsall G. R., Matz L. R., Singh A., ten Seldam R. E. Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristics. Int J Cancer. 1986 Feb 15;37(2):209–215. doi: 10.1002/ijc.2910370207. [DOI] [PubMed] [Google Scholar]
- Jones M. E., Shugg D., Dwyer T., Young B., Bonett A. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust. 1992 Sep 21;157(6):373–378. [PubMed] [Google Scholar]
- Karagas M. R., Thomas D. B., Roth G. J., Johnson L. K., Weiss N. S. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol. 1991 Jan;133(1):58–62. doi: 10.1093/oxfordjournals.aje.a115802. [DOI] [PubMed] [Google Scholar]
- MacKie R., Hunter J. A., Aitchison T. C., Hole D., Mclaren K., Rankin R., Blessing K., Evans A. T., Hutcheon A. W., Jones D. H. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. doi: 10.1016/0140-6736(92)91539-k. [DOI] [PubMed] [Google Scholar]
- Melia J., Cooper E. J., Frost T., Graham-Brown R., Hunter J., Marsden A., Du Vivier A., White J., Whitehead S., Warin A. P. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol. 1995 Mar;132(3):414–421. doi: 10.1111/j.1365-2133.1995.tb08675.x. [DOI] [PubMed] [Google Scholar]
- Melia J., Ellman R., Chamberlain J. Investigating changes in awareness about cutaneous malignant melanoma in Britain using the Omnibus Survey. Clin Exp Dermatol. 1994 Sep;19(5):375–379. doi: 10.1111/j.1365-2230.1994.tb02685.x. [DOI] [PubMed] [Google Scholar]
- Melia J., Ellman R., Chamberlain J. Meeting The Health of the Nation target for skin cancer: problems with tackling prevention and monitoring trends. J Public Health Med. 1994 Jun;16(2):225–232. doi: 10.1093/oxfordjournals.pubmed.a042961. [DOI] [PubMed] [Google Scholar]
- Silcocks P. B., Thornton-Jones H., Skeet R. G. Can we achieve 100% ascertainment in cancer registration? Public Health. 1989 Jan;103(1):23–30. doi: 10.1016/s0033-3506(89)80098-8. [DOI] [PubMed] [Google Scholar]
- Villard-Mackintosh L., Coleman M. P., Vessey M. P. The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer. 1988 Oct;58(4):507–511. doi: 10.1038/bjc.1988.252. [DOI] [PMC free article] [PubMed] [Google Scholar]